Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -171.58% is 12% below its 5-year average of -152.73%, near the high end of its 5-year range (-169160.69%–0.00%).
17.67% above its 12-month average of -208.41%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -220.77%.
OPERATING MARGIN
-171.58%
OPERATING MARGIN AVG TTM
-208.41%
OPERATING MARGIN AVG 3Y
-152.27%
OPERATING MARGIN AVG 5Y
-152.73%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+17.67%
CURRENT VS 3Y AVG
-12.68%
CURRENT VS 5Y AVG
-12.34%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 384 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
bioAffinity Technologies, Inc.
Market Cap
$2.59M
Operating Margin
-171.58%
TTM Avg
-208.41%
3Y Avg
-152.27%
5Y Avg
-152.73%
Market Cap
$2.47M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.37M
Operating Margin
-102380.23%
TTM Avg
-77298.57%
3Y Avg
-57151.39%
5Y Avg
-38807.57%
Market Cap
$3.09M
Operating Margin
-4350.05%
TTM Avg
-3615.82%
3Y Avg
-8354.24%
5Y Avg
-15697.02%
Market Cap
$3.13M
Operating Margin
0.00%
TTM Avg
-11613.39%
3Y Avg
-11298.29%
5Y Avg
-8806.57%
Market Cap
$1.92M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.37M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.44M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-518.01%
5Y Avg
-1135.32%
Market Cap
$3.48M
Operating Margin
-364.24%
TTM Avg
-350.71%
3Y Avg
-763.84%
5Y Avg
-1461.60%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | $2.59M | -171.58% | -208.41% | -152.27% | -152.73% |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.47M | 0.00% | 0.00% | 0.00% | 0.00% |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.37M | -102380.23% | -77298.57% | -57151.39% | -38807.57% |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.09M | -4350.05% | -3615.82% | -8354.24% | -15697.02% |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.13M | 0.00% | -11613.39% | -11298.29% | -8806.57% |
| Autonomix Medical, Inc. (AMIX)vs › | $1.92M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.37M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.44M | 0.00% | 0.00% | -518.01% | -1135.32% |
| Evogene Ltd. (EVGN)vs › | $3.48M | -364.24% | -350.71% | -763.84% | -1461.60% |
| Eocene Ltd. (EOCN)vs › | $3.59M | N/A | N/A | N/A | N/A |
Gross Margin
23.2%
Operating Margin
-171.6%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -220.77% |
| 2026-03-31 | -267.62% |
| 2025-12-31 | -196.94% |
| 2025-09-30 | -158.56% |
| 2025-06-30 | -198.16% |
| 2025-03-31 | -141.73% |
| 2024-12-31 | -133.47% |
| 2024-09-30 | -83.98% |
| 2024-06-30 | -87.08% |
| 2024-03-31 | -80.84% |
| 2023-12-31 | -105.83% |
| 2023-09-30 | -768.72% |
| 2023-06-30 | -9009.78% |
| 2023-03-31 | -169160.69% |
| 2022-12-31 | -69213.17% |
| 2022-09-30 | -84883.13% |
| 2022-06-30 | -52382.77% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
